Issue navigation
Volume 26, Issue 20, October 2005
Editorials
Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend, or foe?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Filippo Crea and Felicita Andreotti
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2075–2076, https://doi.org/10.1093/eurheartj/ehi475
Ischaemia and outcome with normal coronary arteriesThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Thomas H. Marwick
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2077–2078, https://doi.org/10.1093/eurheartj/ehi476
Aldosterone antagonism and atrial fibrillation: time for clinical assessment?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Stanley Nattel
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2079–2080, https://doi.org/10.1093/eurheartj/ehi477
New problems raised by increased pulse pressureThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
Michel E. Safar
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2081–2082, https://doi.org/10.1093/eurheartj/ehi427
Review
Inflammation in the genesis and perpetuation of atrial fibrillation
Mads D.M. Engelmann and Jesper Hastrup Svendsen
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2083–2092, https://doi.org/10.1093/eurheartj/ehi350
Clinical Research
Relationship among pregnancy associated plasma protein-A levels, clinical characteristics, and coronary artery disease extent in patients with chronic stable angina pectoris
Juan Cosin-Sales and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2093–2098, https://doi.org/10.1093/eurheartj/ehi433
CLINICAL VIGNETTES
Acute coronary artery occlusion revealed by ECG-gated 16-slice CT scan of the whole chest
Emmanuel Coche and others
European Heart Journal, Volume 26, Issue 20, October 2005, Page 2098, https://doi.org/10.1093/eurheartj/ehi508
Clinical Research
Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease
Fabrizio Tomai and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2099–2105, https://doi.org/10.1093/eurheartj/ehi356
Extent of ST-segment depression and cardiac events in non-ST-segment elevation acute coronary syndromes
Stefano Savonitto and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2106–2113, https://doi.org/10.1093/eurheartj/ehi395
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry
Karolina E. Szummer and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2114–2119, https://doi.org/10.1093/eurheartj/ehi352
Importance of arterial pulse pressure as a predictor of coronary heart disease risk in PROCAM
Gerd Assmann and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2120–2126, https://doi.org/10.1093/eurheartj/ehi467
Left ventricular wall motion abnormalities as well as reduced wall thickness can cause false positive results of routine SPECT perfusion imaging for detection of myocardial infarction
Heiko Mahrholdt and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2127–2135, https://doi.org/10.1093/eurheartj/ehi387
Long-term survival of patients with chest pain syndrome and angiographically normal or near-normal coronary arteries: the additional prognostic value of dipyridamole echocardiography test (DET)
Rosa Sicari and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2136–2141, https://doi.org/10.1093/eurheartj/ehi408
Diabetes, glucose level, and risk of sudden cardiac death
Xavier Jouven and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2142–2147, https://doi.org/10.1093/eurheartj/ehi376
13-year follow-up of the German angioplasty bypass surgery investigation
Jan Kaehler and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2148–2153, https://doi.org/10.1093/eurheartj/ehi385
Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors
Henry Krum and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2154–2158, https://doi.org/10.1093/eurheartj/ehi409
The Belgian Improvement Study on Oral Anticoagulation Therapy: a randomized clinical trial
Neree Claes and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2159–2165, https://doi.org/10.1093/eurheartj/ehi327
Biomarker-based risk assessment model in acute pulmonary embolism
Maciej Kostrubiec and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2166–2172, https://doi.org/10.1093/eurheartj/ehi336
Outcome of pregnancy in patients after repair of aortic coarctation
Joris W.J. Vriend and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2173–2178, https://doi.org/10.1093/eurheartj/ehi338
CLINICAL VIGNETTES
Persistent left superior vena cava. Use of an innominate vein between left and right superior caval veins for the placement of a right ventricular lead during ICD/CRT implantation
Alf Inge Larsen and Dennis W. Nilsen
European Heart Journal, Volume 26, Issue 20, October 2005, Page 2178, https://doi.org/10.1093/eurheartj/ehi516
Clinical Research
Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect
Salvatore Caputo and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2179–2184, https://doi.org/10.1093/eurheartj/ehi378
Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation
Yasuhide Asaumi and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2185–2192, https://doi.org/10.1093/eurheartj/ehi411
Preclinical research
Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction
Paul Milliez and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2193–2199, https://doi.org/10.1093/eurheartj/ehi478
In vivo temperature heterogeneity is associated with plaque regions of increased MMP-9 activity
Rob Krams and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2200–2205, https://doi.org/10.1093/eurheartj/ehi461
Letters to the Editor
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study
Italo Porto and others
European Heart Journal, Volume 26, Issue 20, October 2005, Page 2206, https://doi.org/10.1093/eurheartj/ehi424
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study: reply
Claudio Cavallini and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2206–2207, https://doi.org/10.1093/eurheartj/ehi425
The emerging role of inflammation in atrial fibrillation and the potential of anti-inflammatory interventions
Panagiotis Korantzopoulos and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2207–2208, https://doi.org/10.1093/eurheartj/ehi450
The emerging role of inflammation in atrial fibrillation and the potential of anti-inflammatory interventions: reply
Mads D.M. Engelmann and Jesper Hastrup Svendsen
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2208–2209, https://doi.org/10.1093/eurheartj/ehi451
Six minute walk test
Lars Olsson and Karl Swedberg
European Heart Journal, Volume 26, Issue 20, October 2005, Page 2209, https://doi.org/10.1093/eurheartj/ehi452
Six minute walk test: reply
Jens Refsgaard
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2209–2210, https://doi.org/10.1093/eurheartj/ehi453
Obstructive sleep apnoea and plasma homocysteine: reply
Anna Svatikova and others
European Heart Journal, Volume 26, Issue 20, October 2005, Pages 2210–2211, https://doi.org/10.1093/eurheartj/ehi486
Obstructive sleep apnoea and plasma homocysteine
Lena Lavie and Peretz Lavie
European Heart Journal, Volume 26, Issue 20, October 2005, Page 2210, https://doi.org/10.1093/eurheartj/ehi122
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals